Oncology Central and Future Oncology: top content from 2020
This article takes a look back at some of the top content over the last year published by Oncology Central and our associated journal, Future Oncology.
This article takes a look back at some of the top content over the last year published by Oncology Central and our associated journal, Future Oncology.
eNRGy is a clinical trial of zenocutuzumab for cancer caused by NRG1 gene fusions. Find out more in our latest journal feature here.
What are the latest developments in diagnostic and therapeutic options for pancreatic cancer patients? Find out in our interview with Mandana Kamgar
eNRGy is a clinical trial of zenocutuzumab for cancer caused by NRG1 gene fusions. Find out more in our latest journal feature here.
What are the latest developments in diagnostic and therapeutic options for pancreatic cancer patients? Find out in our interview with Mandana Kamgar
How can MRI-guided radiation therapy offer in terms of real-time insights into glioblastoma disease progression?
Discover the strides being made to unravel the complexities of brain tumors in our latest interview with Karen Noble.
eNRGy is a clinical trial of zenocutuzumab for cancer caused by NRG1 gene fusions. Find out more in our latest journal feature here.
Explore opportunities for women in neuro-oncology with Dr Macarena Ines De La Fuente who has been the co-chair of the SNO’s Women and Diversity Committee.
What are the latest developments in diagnostic and therapeutic options for pancreatic cancer patients? Find out in our interview with Mandana Kamgar
Unpacking issues in cancer research with Wayne Lawrence. His work on cancer risk and structural racism aims to create a more equitable future.